Danmark - dansk - SEGES Landbrug & Fødevarer

upl europe ltd. (tidligere: united phosphorus ltd.) - napropamid - suspensionskoncentrat - 418,5 g/l napropamid

Danmark - dansk - SEGES Landbrug & Fødevarer

upl europe ltd. (tidligere: united phosphorus ltd.) - napropamid - suspensionskoncentrat - 450 g/l napropamid

Danmark - dansk - SEGES Landbrug & Fødevarer

agrodan a/s - napropamid - vandopløseligt koncentrat - 450 g/l napropamid

Danmark - dansk - SEGES Landbrug & Fødevarer

inter-trade a/s - napropamid - suspensionskoncentrat - 450 g/l napropamid

Den Europæiske Union - dansk - EMA (European Medicines Agency)

ucb pharma s.a. - lacosamid - epilepsier, delvis - antiepileptika, - lacosamide ucb er angivet som monoterapi og tillægsbehandling terapi i behandlingen af delvis-anfald med eller uden sekundær generalisering hos voksne, unge og børn fra 4 år med epilepsi.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

accord healthcare s.l.u. - lacosamid - epilepsi - antiepileptika, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy•         in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. •         in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Danmark - dansk - SEGES Landbrug & Fødevarer

inter-trade a/s - napropamid - flydende middel - 450 g/l napropamid

Den Europæiske Union - dansk - EMA (European Medicines Agency)

extrovis eu ltd. - lacosamid - epilepsi - antiepileptika, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

stada arzneimittel ag - lacosamid - filmovertrukne tabletter - 50 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

krka d.d. novo mesto - lacosamid - filmovertrukne tabletter - 50 mg